Site is under maintenance and we will be back soon. You can e-mail us to standards@synzeal.com for any details required.
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Chemical Name: 2,4-Dichloropyrimidine
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Smiles: ClC1=NC=CC(Cl)=N1
Download MSDS
Analytical control of process impurities in Pazopanib hydrochloride by impurity fate mappingYan Li 1, David Q Liu, Shawn Yang, Ravinder Sudini, Michael A McGuire, Dharmesh S Bhanushali, Alireza S KordJ Pharm Biomed Anal. 2010 Aug 1;52(4):493-507. Determination and characterization of process impurities in pazopanib hydrochloride drug substancemusty sharada, ravichandra babuInt J Pharm Pharm Sci, Vol 8, Issue 4, 97-102 Characterization of forced degradation products of pazopanib hydrochloride by UHPLC‐Q‐TOF/MS and in silico toxicity predictionPrinesh N. Patel Pradipbhai D. Kalariya Mahesh Sharma Prabha Garg M. V. N Kumar Talluri S. Gananadhamu R. SrinivasJournal of mass spectrometry Volume50, Issue7 July 2015 Pages 918-928 Development and validation of a stability indicating RP-HPLC method for the determination of Pazopanib in bulk drug and its pharmaceutical dosage formKishore Kumar Reddy Y, J. Raveendra Reddy and N. DevannaJ. Chem. Pharm. Res., 2015, 7(9):127-132 Validated RP-HPLC Method Development of Pazopanib in Bulk and its Pharmaceutical Dosage FormKiran Kumar Buralla, and Varadarajan ParthasarathyPharmaceutical Methods,2020,11,1,21-24.
Pazopanib Impurity 13 is chemically 2,4-Dichloropyrimidine. Pazopanib Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Pazopanib Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pazopanib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
